Garland J. Scott
Transactions
50
Companies
10
Filings
8
CIK
0001533228
Recent Transactions
- Award
- Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−28,700→ 0 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+32,335→ 32,335 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−48,072→ 0 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+37,500→ 37,500 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−37,500→ 0 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+28,700→ 28,700 total - Award
Stock Option (right to buy Common Stock)
2025-11-06+48,072→ 48,072 total - Disposition to Issuer
Stock Option (right to buy Common Stock)
2025-11-06−32,335→ 0 total - Disposition to Issuer
- Award
- Award
- Disposition to Issuer
- Award
- Award
- Award
Stock Option (right to buy Common Stock)
2025-06-02+22,500→ 22,500 total - Award
Deferred Restricted Stock Unit (RSU)
2025-06-02+15,000→ 15,000 total - Award
- Award
- Award
- Award
Stock Option (right to buy Common Stock)
2024-05-23+32,335→ 32,335 total - Award
- Award
- Award
Director Stock Option (Right to buy Common Stock)
2023-06-22+37,500→ 37,500 total - Award
- Award
- Award
Director Stock Option (Right to buy Common Stock)
2022-06-21+28,700→ 28,700 total - Award
- Award
Stock Option (Right to buy Common Stock)
2021-08-16+48,072→ 48,072 total - Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Award
- Tax Payment
- Award
- Award
- Tax Payment
- Award
Nonstatutory Stock Option (right to buy)
2019-06-06+25,000→ 25,000 total - Award
- Award
- Award
- Award
Companies
10- $ALXO
ALX ONCOLOGY HOLDINGS INC
Director
Calithera Biosciences, Inc.
Director
- $DAWN
Day One Biopharmaceuticals, Inc.
Director
- $ELVN
Enliven Therapeutics, Inc.
Director
- $EXEL
EXELIXIS, INC.
EVP & Chief Commerical Officer
- $KPTI
Karyopharm Therapeutics Inc.
Director
- $LBRX
LB PHARMACEUTICALS INC
Director
- $OLMA
Olema Pharmaceuticals, Inc.
Director
PORTOLA PHARMACEUTICALS INC
Director, President and CEO
Relypsa Inc
SVP & Chief Commercial Officer
Recent Filings
8Address
C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD
BOULDER, CO, 80301